PDIA3P1 and esophageal squamous cell carcinoma: Our findings integrate lncRNA biology, cellular metabolism, histone modifications, and RNA modification regulation, offering new insights into ESCC progression and suggesting that PDIA3P1 could serve as a novel therapeutic target for ESCC (Figure10).